Patankar Sanjiv K, Larach Sergio W, Ferrara Andrea, Williamson Paul R, Gallagher Joseph T, DeJesus Samuel, Narayanan Shekar
The Colon and Rectal Clinic of Orlando, 110 West Underwood Street, Orlando, Florida 32806, USA.
Dis Colon Rectum. 2003 May;46(5):601-11. doi: 10.1007/s10350-004-6616-z.
The aim of this study was to define the long-term oncologic outcomes of laparoscopic resections for colorectal cancer.
We analyzed our experience via a prospective, nonrandomized, longitudinal cohort study. The period of study extended from April 1991 to May 2001. Laparoscopic resection was offered selectively in the absence of a large mass, invasion into abdominal wall or adjacent organs, and multiple prior abdominal operations. Every laparoscopic resection performed with curative intent for adenocarcinoma was included. Twenty percent of patients whose procedures were converted to open resection were included in the laparoscopic-resection group because of intention to treat. Oncologic outcome measures of this group were compared with a computerized, case-matched, open-resection group, the case-matching variables being age, gender, site of primary tumor (colon vs. rectum), and TNM stage. The laparoscopic-resection group was followed up prospectively, and data were updated regularly. The follow-up techniques consisted of a combination of office visits, telephone calls, and the United States Social Security Death Index database.
The laparoscopic-resection group consisted of 172 patients with a mean age of 67 (range, 27-85) years. The open-resection group consisted of 172 patients with a mean age of 69 (range, 30-90) years. Mean follow-up was 52 (range, 3-128) months. Complete (100 percent) follow-up data were available. The TNM stage distribution was 63 Stage I (37 percent), 51 Stage II (30 percent), 47 Stage III (27 percent), and 11 Stage IV (6 percent) tumors for the laparoscopic-resection group and 65 Stage I (38 percent), 48 Stage II (28 percent), 51 Stage III (29 percent), and 8 Stage IV (5 percent) tumors for patients in the open-resection group (P = 0.75, not significant). Thirty-day mortality was 1.2 percent (2 deaths) in the laparoscopic-resection group and 2.4 percent (4 deaths) in the open-resection group (P > 0.05, not significant). Early and late complication incidences were comparable. Local recurrence was observed in three patients (1.7 percent) in the laparoscopic resection group with the primary tumor in the colon and in three patients (1.7 percent) with the primary tumor in the rectum, for a total incidence of local recurrence in the laparoscopy group of 3.5 percent (6 patients). In the open-resection group, local recurrence was observed in two patients (1.2 percent) among those with primary tumor site in the colon and in three patients (1.7 percent) in the group with primary tumor in the rectum, for a total incidence of local recurrence in the open-resection group of 2.9 percent (5 patients). One of the local recurrences in the laparoscopy group occurred in the port/extraction site, for an incidence of 0.6 percent. Metastasis occurred in 18 patients (10.5 percent) in the open group and in 21 (12.2 percent) in the laparoscopy group. Stage-for-stage overall five-year survival rates were similar in the two groups. The Kaplan-Meier statistical analysis performed for colonic vs. rectal primary adenocarcinoma confirmed that TNM stage for stage-overall survival was similar in the laparoscopic and open-resection groups (log-rank P = 0.22).
Notwithstanding the drawbacks of a nonrandomized study, no adverse long-term oncologic outcomes of laparoscopic resections for colorectal cancer were observed in a single center's experience during a ten-year period.
本研究旨在明确腹腔镜结直肠癌切除术的长期肿瘤学结局。
我们通过一项前瞻性、非随机、纵向队列研究分析了我们的经验。研究时间段从1991年4月至2001年5月。在不存在大肿块、未侵犯腹壁或邻近器官以及既往未进行多次腹部手术的情况下,选择性地进行腹腔镜切除术。每例以根治性意图进行的腺癌腹腔镜切除术均纳入研究。因治疗意图,20%转为开腹手术的患者被纳入腹腔镜切除组。将该组的肿瘤学结局指标与计算机匹配的开腹手术组进行比较,病例匹配变量为年龄、性别、原发肿瘤部位(结肠与直肠)和TNM分期。对腹腔镜切除组进行前瞻性随访,并定期更新数据。随访技术包括门诊就诊、电话随访以及美国社会保障死亡指数数据库。
腹腔镜切除组有172例患者,平均年龄67岁(范围27 - 85岁)。开腹手术组有172例患者,平均年龄69岁(范围30 - 90岁)。平均随访时间为52个月(范围3 - 128个月)。可获得完整(100%)的随访数据。腹腔镜切除组的TNM分期分布为:63例I期(37%)、51例II期(30%)、47例III期(27%)、11例IV期(6%)肿瘤;开腹手术组患者的TNM分期分布为:65例I期(38%)、48例II期(28%)、51例III期(29%)、8例IV期(5%)肿瘤(P = 0.75,无显著差异)。腹腔镜切除组30天死亡率为1.2%(2例死亡),开腹手术组为2.4%(4例死亡)(P > 0.05,无显著差异)。早期和晚期并发症发生率相当。腹腔镜切除组中,3例(1.7%)结肠原发性肿瘤患者和3例(1.7%)直肠原发性肿瘤患者出现局部复发,腹腔镜组局部复发总发生率为3.5%(6例)。在开腹手术组中,结肠原发性肿瘤部位的患者中有2例(1.2%)出现局部复发,直肠原发性肿瘤组中有3例(1.7%)出现局部复发,开腹手术组局部复发总发生率为2.9%(5例)。腹腔镜组中有1例局部复发发生在切口/取标本部位,发生率为0.6%。开腹组有18例患者(10.5%)发生转移,腹腔镜组有21例(12.2%)发生转移。两组各分期的总体五年生存率相似。对结肠与直肠原发性腺癌进行的Kaplan - Meier统计分析证实,腹腔镜组和开腹手术组各分期的总体生存率相似(对数秩检验P = 0.22)。
尽管本研究存在非随机的缺陷,但在单一中心十年的经验中,未观察到腹腔镜结直肠癌切除术有不良的长期肿瘤学结局。